2+ uptake regulates diverse endothelial cell functions and has also been related to nitric oxide 
• production was independent of eNOS phosphorylation at serine 1177 . Our findings emphasize that manipulating mitochondrial Ca 2+ uptake may represent a novel strategy to control eNOS-mediated NO • production.
Introduction
The transfer of Ca 2+ into mitochondria influences cell signaling and functions by various means. The organelles themselves immediately respond to Ca 2+ elevations as they house Ca 2+ -sensitive enzymes and transporters [1] . Ca 2+ within mitochondria is known to elevate their metabolic activity, but can also trigger cell death [2, 3] . In addition, mitochondrial Ca 2+ uptake and release shapes local and global cellular Ca 2+ signals, which control a variety of cell signaling events [4] .
Particularly, in vascular endothelial cells mitochondrial Ca 2+ signals have been debated to directly or indirectly control key functions such as the synthesis and release of vasoactive compounds [5, 6] . However, the exact role of mitochondrial Ca 2+ uptake for endothelial nitric oxide (NO • ) production, which is accomplished predominately by the Ca 2+ calmodulin-dependent endothelial nitric oxide synthase (eNOS) [7] , is unknown. While mitochondria-derived NO • has been detected in isolated mitochondria and permeabilized endothelial cells [5, 8] , the impact of mitochondrial Ca 2+ uptake on Ca 2+ -evoked NO • production in intact cells has not been investigated so far. In recent years the key components of mitochondrial Ca 2+ channels have been identified [9, 10] . These studies unveiled that the mitochondrial Ca 2+ uniporter basically consists of the pore forming mitochon-drial calcium uniporter (MCU) [9] , the essential MCU regulator (EMRE) [11] , and the mitochondrial calcium uptake 1 (MICU1) [10] . Interestingly, MICU1 shields the MCU/EMRE-dependent mitochondrial Ca 2+ channel and thereby impedes mitochondrial Ca 2+ uptake under basal conditions [11] . A very recent study unveiled that MICU1 methylation by protein arginine methyltransferase-1 (PRMT1) hampers MCU activation by Ca 2+ , indicating that mitochondrial Ca 2+ uptake is tightly controlled by posttranslational modifications [12] . However, the knock-down of these key components of the mitochondrial Ca 2+ uniporter allows to efficiently manipulate mitochondrial Ca 2+ uptake [13] . 
Materials and methods

Chemicals
Dulbecco's modified Eagle's medium (DMEM), antimycin, oligomycin, and L-N G -nitro arginine were purchased from Sigma-Aldrich (Vienna, Austria). Fura-2-acetoxymethyl ester (fura-2/am), tetramethylrhodamine methyl ester perchlorate (TMRM) and cell culture supplements were obtained from Invitrogen (San Diego, USA). TransFast™ transfection reagent was obtained from Promega (Mannheim, Germany). Antibodies against total and phosphorylated eNOS (pS1177) were from BD Transduction Laboratories™, alphatubulin was from Cell Signaling Technology®. Adenosine-5´-triphosphate (ATP) and all other chemicals were purchased from Roth (Karlsruhe, Germany) unless otherwise indicated.
Cell culture, transfection and adenoviral transduction
The human umbilical vein endothelial cell line EA.hy92 (passage 35-45) [16] was cultured in DMEM medium containing 1% HAT (5 mM hypoxanthine, 20 µM aminopterin, 0.8 mM thymidine), 10% fetal bovine serum, 100 U/ml penicillin, and 100 µg/ml streptomycin in a humidified incubator (37°C, 5% CO 2 ). Human embryonic kidney cells HEK293 were grown in a culture medium without HAT. Prior to transfection or adenoviral transduction cells were plated on 30 mm glass cover slips. At 50-60% confluence, cells were co-transfected with 100 µM of the respective siRNA(s) and 1.5 µg of a plasmid coding either for the NO
• -sensitive probe G-geNOp, its mutated NO • -insensitive negative control (G-geNOp mut ) (NGFI Next Generation Fluorescence Imaging GmbH, Graz, Austria), the mitochondrial cameleon 4mtD3cpv or the endothelial nitric oxide synthase C-terminally fused to a red fluorescent protein (eNOS-RFP) as described previously [13] . All siRNAs were purchased from Microsynth (Balgach, Switzerland) and their (5´−3´) sequences were: GCAGCUCAAGAAGCACUUCAA (hMICU1-si1), GCAAUGGCGAACUGAGCAAUA (hMICU1-si2), AGAAG-UCUGUGAUGAUAAA (hMICU1-si3), GCCAGAGACAGACAAUACU (hMCU-si1), GGAAAGGGAGCUUAUUGAA (hMCU-si2), GAACUUUG-CUGCUCUACUU (hEMRE-si) and a scrambled negative control siRNA UUCUCCGAACGUGUCACGU (Scrambled siRNA). Human umbilical vein endothelial cells (HUVECs) (CC-2519; Lonza, Basel, Switzerland) were grown at 37°C and 5% CO 2 on tissue culture dishes coated with 1% Gelatin (#49391; Sigma) in endothelial basal medium (EBM) culture medium (CC-3121; Lonza) supplemented with endothelial growth medium (EGM) SingleQuots and growth factors (CC-4143; Lonza). HUVECs were cultured maximally 14 days before experiments. For imaging experiments HUVECs were seeded on 1% Gelatin coated 30 mm glass cover slips. At a confluence of 50-60% siRNA transfections and infection of BacMam 4mtD3cpv virus (Life Technologies, Vienna, Austria) encoding the mitochondrial cameleon was performed as recently described [12] . The G-geNOp expression in endothelial cells was achieved by adenoviral transduction at a multiplicity of infection (MOI) of 10 for HUVECs or MOI 1000 for EA.hy926 cells. All experiments were performed 42-54 h after transfection or infection, respectively. 
Buffer solutions for imaging experiments
Immunoblotting
Transfected EA.hy926 cells (siControl, siMCU/EMRE or siMICU1) were incubated with vehicle (water) or 100 µM ATP at 37°C for 3 or 5 min. Cells were then harvested and homogenized by sonication (3×5 s) in ice-cold RIPA lysis buffer (Sigma, Vienna, Austria) containing 2 mM EDTA, protease and phosphatase inhibitors (CompleteTM, PhosSTOPTM, Roche, Vienna, Austria). Protein concentration was determined with the PierceTM BCA Protein Assay Kit using bovine serum albumin as standard (Fisher Scientific Austria GmbH, Vienna, Austria). Denatured samples (30 µg) were separated by SDS-PAGE on 10% gels and transferred electrophoretically to nitrocellulose membranes. After blocking with 5% non-fat dry milk in Tris-buffered saline containing 0.1% (v/v) TWEEN-20 for 1 h, membranes were incubated overnight at 4°C with a primary antibody against eNOS (1:2000; BD Transduction Laboratories), Ser 1177 phospho-eNOS (1:1000; BD Transduction Laboratories) or β-actin (1:200,000; Sigma). Thereafter, membranes were washed 3 times and incubated for 1 h with a horseradish peroxidase-conjugated anti-mouse IgG secondary antibody (1:5000). Immunoreactive bands were visualized by chemiluminescence using ECL detection reagent (Biozym, Germany) and quantified densitometrically using the Fusion SL system (Peqlab, Erlangen, Germany).
Statistical analyses
The acquired data were analyzed by the GraphPad Prism software version 5.04 (GraphPad Software, San Diego, CA, USA). Data are presented as mean ± standard error of mean (SEM) of independent experiments (N) throughout the whole manuscript. For comparisons between two groups, two-tailed Student t-test was used for evaluation of statistical significance and a p value between 0.01 and 0.05 (pStudent´s t-test) was considered significant and indicated with "*", p between 0.001 and 0.01 as very significant with "**" and p < 0.001 as highly significant with "***". For comparisons across multiple groups, one-way ANOVA with Barlett's test for equal variances and Tukey's Multiple Comparision test were used for evaluating statistical significance expressed as described above. Data shown are either average or representative curves of at least three independent experiments, including analyses from imaging and western blot experiments.
Results
Real-time monitoring of NO
• production in single endothelial cells experimental conditions [15] . while the basal cytosolic Ca 2+ levels were identical in both cell types (Fig. 3A) . Respective mitochondrial Ca 2+ elevations tended to be stronger in the primary endothelial cells (Fig. 3B) . In average the ATP-evoked NO • signals in HUVECs expressing G-geNOp (Fig. 3C) were less pronounced and occurred with rather slow kinetics compared to the faster and stronger NO • elevations in EA.hy926 cells (Fig. 3C) .
Nevertheless, the knock down of MCU and EMRE, which reduced mitochondrial Ca 2+ signals in HUVECs (Fig. 3D) , also resulted in diminished ATP-evoked NO • formation in the primary endothelial cells (Fig. 3E) . The siRNA-mediated knock-down of MCU and EMRE significantly reduced both the amplitude and slope of ATP-triggered NO • signals in HUVECs (Fig. 3E ).
Mitochondrial depolarization reduces Ca
2+
-triggered NO • formation in
EA.hy926 cells
The impact of impaired mitochondrial Ca 2+ uptake was studied by depolarization of the mitochondrial membrane potential with a combination of oligomycin and antimycin ( Fig. 4A and B) . In the presence of these compounds the Ca 2+ -triggered NO • signal was significantly reduced in response to Ca 2+ release and entry (Fig. 4C) . The fluores- (Fig. 5C, right panel) . In primary HUVECs siRNA-mediated silencing of MICU1 also increased mitochondrial Ca 2+ signals in response to ATP (Fig. 5D) . However, the ATP-induced NO • formation (Fig. 5D ) was only slightly increased in HUVECs that had been treated with siRNA against MICU1 compared to respective control cells (Fig. 5E ).
The eNOS expression levels as well as basal and ATP-stimulated eNOS phosphorylation remain unaffected by silencing MCU, EMRE or MICU1
Phosphorylation of several sites within the eNOS protein significantly modulates its activity [25] . Particularly, eNOS phosphorylation at serine 1177 is known to enhance its activity [25, 26] . Accordingly, we performed western blot analysis using EA.hy926 cells to investigate whether or not the knock-down of MCU/EMRE and MICU1 affects eNOS phosphorylation at serine 1177 . As shown in Fig. 6 the knock-down of neither MCU/EMRE nor MICU1 affected eNOS phosphorylation under basal (unstimulated) conditions. Cell treatment with ATP raised eNOS phosphorylation levels within 3 and 5 min (Fig. 6) , while the ATP-induced increase of phosphorylated eNOS (peNOS) was not altered by MCU/EMRE and MICU1 silencing (Fig. 6 ). In line with these findings the expression of eNOS in EA.hy926 cells was not affected by knockdown of MCU/EMRE or MICU1 (total eNOS, Fig. 6A There is general agreement that eNOS is mainly localized at the plasma membrane [27] . However, in a previous study it has been suggested that mitochondrial Ca 2+ uptake stimulates NO • formation by a mitochondrial NOS isoform in bovine endothelial cells [5] . Therefore, we transiently expressed wild-type eNOS-RFP in HEK293 cells, which do not express any NOS isoforms. Confocal microscopy of eNOS-RFP expressing HEK293 cells confirmed that the NO
• -generating enzyme is located predominately at the plasma membrane and intracellular vesicular structures but not within mitochondria of cells (Fig. 7A) . HEK293 cells expressing eNOS-RFP showed a considerable increase of cellular NO
• levels in response to the IP 3 -generating agonist ATP (Fig. 7B ). Control cells which were not transfected with eNOS-RFP were unable to produce NO • upon the addition of the agonist (Fig. 7B) .
However, the response of the NO • probe to the NO
• -donor sodium nitroprusside (SNP) was the same in both control (HEK) and eNOS-RFP expressing HEK293 cells (HEK + eNOS-RFP) (Fig. 7B) . Knock-down of MCU/EMRE in HEK293 cells significantly reduced mitochondrial Ca 2+ signals in response to ATP (Fig. 7C) , while the respective cytosolic Ca 2+ elevation remained unaffected by silencing these MCU components (Fig. 7D) . As expected, knock-down of MICU1 resulted in increased mitochondrial Ca 2+ -levels and uptake without affecting respective cytosolic Ca 2+ signals (Fig. 7C and D) . In line with our results using primary endothelial cells ATP-evoked NO • -signals were significantly reduced in cells silenced of MCU and EMRE (Fig. 7E) [24] and/or contributing to the availability of essential NOS cofactors [37] . Further experiments are necessary to clarify by which molecular mechanisms mitochondrial Ca 2+ uptake supports NO • production by eNOS. In this study we could, however, exclude that eNOS phosphorylation at serine 1177 , which is known to enhance eNOS activity [25, 26] homeostasis represents a promising approach to therapeutically inter- vene in endothelium-governed NO
• -dependent vasoreactivity. However, the availability of pharmacological tools that specifically target the MCU machinery is very limited. We used a combination of oligomycin, an inhibitor of the ATP synthase, and antimycin, an inhibitor of complex III, in order to abolish mitochondrial Ca 2+ uptake indirectly.
This kind of cell treatment strongly affects the metabolic activity of the organelle and can lead to a severe cellular ATP depletion [42] , which in turn affects the local and global cellular Ca 2+ homeostasis [24] . While our data show that cell treatment with the mitochondria depolarizing compounds reduces eNOS-mediated NO • production in response to the IP 3 -generating agonist in EA.hy926 cells, the molecular mechanisms responsible for this effect on eNOS activity might be different from those in cells with reduced levels of MCU components. Due to the lack of suitable agents that specifically target the mitochondrial Ca 2+ homeostasis, the impact of an acute alteration of mitochondrial Ca 2+ fluxes on eNOS activity is difficult to investigate. It is possible that the siRNA-mediated knock-down of components of the MCU machinery introduces secondary effects on the cellular bioenergetics that may interfere with eNOS function. Such effects cannot be ruled out, although other studies have demonstrated that silencing or even the knock-out of MCU components have surprisingly little impact on the cellular metabolic homeostasis in situ [12] and in vivo [43, 44] . Eventually, our data suggest that manipulating mitochondrial Ca 
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